Correlation Between Catalyst Pharmaceuticals and Gallant Venture
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Gallant Venture at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Gallant Venture into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Gallant Venture, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Gallant Venture and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Gallant Venture. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Gallant Venture.
Diversification Opportunities for Catalyst Pharmaceuticals and Gallant Venture
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Catalyst and Gallant is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Gallant Venture in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gallant Venture and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Gallant Venture. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gallant Venture has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Gallant Venture go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Gallant Venture
If you would invest 2,152 in Catalyst Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 167.00 from holding Catalyst Pharmaceuticals or generate 7.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. Gallant Venture
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| Gallant Venture |
Catalyst Pharmaceuticals and Gallant Venture Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and Gallant Venture
The main advantage of trading using opposite Catalyst Pharmaceuticals and Gallant Venture positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Gallant Venture can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gallant Venture will offset losses from the drop in Gallant Venture's long position.| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
| Gallant Venture vs. Companhia Paranaense de | Gallant Venture vs. Otter Tail | Gallant Venture vs. Brookfield Infrastructure Partners | Gallant Venture vs. RWE AG PK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |